These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33268243)

  • 1. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
    Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A
    Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
    Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
    Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
    Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
    Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
    Fang Y; Yan D; Wang L; Zhang J; He Q
    J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma.
    Shehab-Eldeen S; Metwaly MF; Saber SM; El-Kousy SM; Badr EAE; Essa A
    Dig Liver Dis; 2023 Feb; 55(2):283-290. PubMed ID: 35525722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
    World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
    El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
    Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
    PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
    Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma.
    Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.